[Skip to Navigation]
Views 137
Citations 0
Comment & Response
September 2017

All Types of Hemorrhagic Stroke Are Not Created Equally—Reply

Author Affiliations
  • 1Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark
  • 2Department of Cardiology, Atrial Fibrillation Study Group, Aalborg University Hospital, Aalborg, Denmark
  • 3University of Birmingham Institute for Cardiovascular Sciences, City Hospital, Birmingham, England
JAMA Intern Med. 2017;177(9):1399. doi:10.1001/jamainternmed.2017.3240

In Reply Decision making on the use of oral anticoagulant treatment in patients with atrial fibrillation is often uncomplicated due to the positive risk-benefit ratio, ie, balancing risk of bleeding against benefit from thromboprophylaxis. Observational data on patients with atrial fibrillation sustaining an intracranial hemorrhage are increasing, recognizing the treatment conundrum of resuming oral anticoagulant treatment since the risk-benefit ratio of treatment is shifted substantially.

Add or change institution